Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

COMPUGROUP MEDICAL SE & CO. KGAA

(COP)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

CompuGroup Medical SE & Co. KGaA: Share Buy-Back Program - 4th Interim Announcement

03/29/2021 | 12:19pm EST

DGAP Post-admission Duties announcement: CompuGroup Medical SE & Co. KGaA / Share Buy-back
CompuGroup Medical SE & Co. KGaA: Share Buy-Back Program - 4th Interim Announcement

29.03.2021 / 18:17
Dissemination of a Post-admission Duties announcement transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Disclosure pursuant to Art. 5 para. 1 lit. b) and para. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 para. 2 and para. 3 of the Commission Delegated Regulation (EU) No 2016/1052

CompuGroup Medical SE & Co. KGaA: Share Buy-Back Program - 4th Interim Announcement

In the period from March 22, 2021 until and including March 26, 2021, CompuGroup Medical SE & Co. KGaA has bought back an aggregate number of 123,746 shares in CompuGroup Medical SE & Co. KGaA within its share buy-back program which had been announced on February 25, 2021 pursuant to Art. 2 para. 1 Commission Delegated Regulation (EU) No 2016/1052 to start on February 26, 2021 and which has been increased and extended as per announcement on March 25, 2021.

The aggregate number of shares bought back each day during the period from March 22, 2021 until and including March 26, 2021 as well as the daily volume-weighted average prices for such buy-backs are as follows:

Date Aggregate volume (number of no-par value shares) Volume-weighted average price (in EUR, excluding ancillary costs and charges)
March 22, 2021 33,327 69.8944
March 23, 2021 16,556 71.9930
March 24, 2021 22,623 71.8178
March 25, 2021 22,426 71.9075
March 26, 2021 28,814 72.2724
Total: 123,746 71.4453
 

The aggregate number of shares bought back within the share buy-back program in the period from February 26, 2021 until and including March 26, 2021 amounts to 528,814 shares.

Detailed information about the transactions are published on the company's website under www.cgm.com/sbb.

The acquisitions of the shares in CompuGroup Medical SE & Co. KGaA were carried out by a credit institution assigned by CompuGroup Medical SE & Co. KGaA exclusively via the Frankfurt Stock Exchange (XETRA trading).

Koblenz, March 29, 2021

CompuGroup Medical SE & Co. KGaA
The general partner



29.03.2021 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: CompuGroup Medical SE & Co. KGaA
Maria Trost 21
56070 Koblenz
Germany
Internet: www.cgm.com

 
End of News DGAP News Service

1179433  29.03.2021 

fncls.ssp?fn=show_t_gif&application_id=1179433&application_name=news&site_id=zonebourse_sftp

ę EQS 2021
All news about COMPUGROUP MEDICAL SE & CO. KGAA
12/06COMPUGROUP MEDICAL SE & CO. KGAA : Share Buy-Back Program - 1st Interim Announcement
EQ
11/25CompuGroup Medical To Launch $42 Million Share Buyback
MT
11/25COMPUGROUP MEDICAL SE & CO. KGAA : Release of a capital market information
EQ
11/25CompuGroup Medical SE & Co. KGaA adopts resolution on share buy-back program for up to ..
EQ
11/11COMPUGROUP MEDICAL : Gets a Buy rating from Berenberg
MD
11/09COMPUGROUP MEDICAL : Baader Bank remains a Sell rating
MD
11/08COMPUGROUP MEDICAL : Kepler Cheuvreux gives a Neutral rating
MD
11/04CompuGroup Medical SE & Co. KGaA Reports Earnings Results for the Third Quarter and Nin..
CI
11/04COMPUGROUP MEDICAL : Kepler Cheuvreux remains Neutral
MD
11/04COMPUGROUP MEDICAL : Gets a Buy rating from Warburg Research
MD
More news
Analyst Recommendations on COMPUGROUP MEDICAL SE & CO. KGAA
More recommendations
Financials
Sales 2021 1 022 M 1 153 M 1 153 M
Net income 2021 80,6 M 90,9 M 90,9 M
Net Debt 2021 512 M 577 M 577 M
P/E ratio 2021 45,2x
Yield 2021 0,83%
Capitalization 3 594 M 4 040 M 4 053 M
EV / Sales 2021 4,02x
EV / Sales 2022 3,73x
Nbr of Employees 8 079
Free-Float 48,8%
Chart COMPUGROUP MEDICAL SE & CO. KGAA
Duration : Period :
CompuGroup Medical SE & Co. KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends COMPUGROUP MEDICAL SE & CO. KGAA
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 10
Last Close Price 68,15 €
Average target price 84,80 €
Spread / Average Target 24,4%
EPS Revisions
Managers and Directors
Dirk W÷ssner Chairman-Management Board & CEO
Philipp von Ilberg Chairman-Supervisory Board
Frank Brecher Chief Technology Officer
Sven Thomas MŘller Vice Chairman & Chief Information Officer
Ulrike Handel Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
COMPUGROUP MEDICAL SE & CO. KGAA-13.30%3 881
ORACLE CORPORATION37.49%243 134
SAP SE8.47%154 714
SERVICENOW, INC.12.01%122 688
CONSTELLATION SOFTWARE INC.32.42%36 281
HUBSPOT, INC.93.13%33 661